The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: The Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation (ADVANCE) Study

Diabetologia

Volumn 53, Issue 5, 2010, Pages 821-831

  Kengne, A P ^a   Patel, A ^a   Colagiuri, S ^b   Heller, S ^c   Hamet, P ^d   Marre, M ^e   Pan, C Y ^f   Zoungas, S ^a,g   Grobbee, D E ^h   Neal, B ^a   Chalmers, J ^a   Woodward, M ^a,i  

^a UNIVERSITY OF SYDNEY   (Australia)

^b University of Sydney   (Australia)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^e BICHAT HOSPITAL   (France)

^f Army General Hospital   (China)

^g MONASH UNIVERSITY   (Australia)

^h UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

ⁱ MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Calibration; Cardiovascular disease; Diabetes mellitus; Discrimination; Risk prediction

Indexed keywords

GLICLAZIDE; INDAPAMIDE PLUS PERINDOPRIL; PLACEBO;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ETHNICITY; FEMALE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELIABILITY; RISK ASSESSMENT; SEX; STROKE; TREATMENT RESPONSE;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERTENSION; HYPOGLYCEMIC AGENTS; INDAPAMIDE; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PATIENT SELECTION; PERINDOPRIL; RISK; RISK ASSESSMENT; RISK FACTORS;

EID: 77952090266     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-010-1681-4     Document Type: Article

References (37)

1. T Gordon WB Kannel 1982 Multiple risk functions for predicting coronary heart disease: the concept, accuracy, and application Am Heart J 103 1031 1039 10.1016/0002-8703(82)90567-1 1:STN:280:DyaL383gtlSnug%3D%3D 7044082 (Pubitemid 13137891)
2. International Task Force for Prevention of Coronary Heart Disease, International Atherosclerosis Society (2003) Pocket guide to prevention of coronary heart disease. Born Bruckmeier, Munster
3. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults 2002 Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 106 3143 3421
4. AV Chobanian GL Bakris HR Black, et al. 2003 The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report JAMA 289 2560 2572 10.1001/jama.289.19. 2560 1:CAS:528:DC%2BD3sXjvFCqtrk%3D 12748199 (Pubitemid 37430158)
5. SM Haffner S Lehto T Ronnemaa K Pyorala M Laakso 1998 Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction N Engl J Med 339 229 234 10.1056/NEJM199807233390404 1:STN:280:DyaK1czivVKgsg%3D%3D 9673301 (Pubitemid 28350165)
6. Asia Pacific Cohort Studies Collaboration 2006 Coronary risk prediction for those with and without diabetes Eur J Cardiovasc Prev Rehabil 13 30 36 10.1097/00149831-200602000-00005
7. M Woodward P Brindle H Tunstall-Pedoe 2007 Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC) Heart 93 172 176 10.1136/hrt.2006.108167 17090561 (Pubitemid 46180289)
8. KM Anderson PM Odell PW Wilson WB Kannel 1991 Cardiovascular disease risk profiles Am Heart J 121 293 298 10.1016/0002-8703(91)90861-B 1:STN:280:DyaK3M%2FovF2qtg%3D%3D 1985385
9. RJ Stevens V Kothari AI Adler IM Stratton 2001 The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56) Clin Sci (Lond) 101 671 679 10.1042/CS20000335 1:STN:280:DC%2BD3MnnvVOrtQ%3D%3D (Pubitemid 33135349)
10. KM Anderson PW Wilson PM Odell WB Kannel 1991 An updated coronary risk profile. A statement for health professionals Circulation 83 356 362 1:STN:280:DyaK3M%2FosV2ktw%3D%3D 1984895
11. V Kothari RJ Stevens AI Adler, et al. 2002 UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine Stroke 33 1776 1781 10.1161/01.STR.0000020091.07144.C7 12105351 (Pubitemid 34761059)
12. PT Donnan L Donnelly JP New AD Morris 2006 Derivation and validation of a prediction score for major coronary heart disease events in a U.K. type 2 diabetic population Diabetes Care 29 1231 1236 10.2337/dc05-1911 16732001 (Pubitemid 44125915)
13. RJ Stevens RL Coleman AI Adler IM Stratton DR Matthews RR Holman 2004 Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66 Diabetes Care 27 201 207 10.2337/diacare.27.1.201 14693990 (Pubitemid 38196733)
14. A Patel S MacMahon J Chalmers, et al. 2007 Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial Lancet 370 829 840 10.1016/S0140-6736(07)61303-8 1:CAS:528:DC%2BD2sXhtVWjs7zO 17765963 (Pubitemid 47362321)
15. A Patel S MacMahon J Chalmers, et al. 2008 Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes N Engl J Med 358 2560 2572 10.1056/NEJMicm066227 1:CAS:528:DC%2BD1cXnt1yht7s%3D 18539916 (Pubitemid 351214289)
16. RB D'Agostino Sr RS Vasan MJ Pencina, et al. 2008 General cardiovascular risk profile for use in primary care: the Framingham Heart Study Circulation 117 743 753 10.1161/CIRCULATIONAHA.107.699579 18212285 (Pubitemid 351640675)
17. ER DeLong DM DeLong DL Clarke-Pearson 1988 Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach Biometrics 44 837 845 10.2307/2531595 1:STN:280:DyaL1M%2Fns12ksQ%3D%3D 3203132
18. B Rockhill D Spiegelman C Byrne DJ Hunter GA Colditz 2001 Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention J Natl Cancer Inst 93 358 366 10.1093/jnci/93.5.358 1:STN:280:DC%2BD3M7pvVWruw%3D%3D 11238697 (Pubitemid 32229380)
19. Asia Pacific Cohort Studies Collaboration 2007 Cardiovascular risk prediction tools for populations in Asia J Epidemiol Community Health 61 115 121 10.1136/jech.2005.044842 (Pubitemid 46174217)
20. Hosmer DW, Lemeshow S (1989) Applied logistic regression. Wiley, New York
21. PW Wilson RB D'Agostino D Levy AM Belanger H Silbershatz WB Kannel 1998 Prediction of coronary heart disease using risk factor categories Circulation 97 1837 1847 1:STN:280:DyaK1c3msVOjsA%3D%3D 9603539 (Pubitemid 28213628)
22. PA Wolf RB D'Agostino AJ Belanger WB Kannel 1991 Probability of stroke: a risk profile from the Framingham Study Stroke 22 312 318 1:STN:280: DyaK3M7msFWgtA%3D%3D 2003301
23. P Brindle J Emberson F Lampe, et al. 2003 Predictive accuracy of the Framingham coronary risk score in British men: prospective cohort study BMJ 327 1267 10.1136/bmj.327.7426.1267 14644971 (Pubitemid 37487285)
24. HC van Houwelingen 2000 Validation, calibration, revision and combination of prognostic survival models Stat Med 19 3401 3415 10.1002/1097-0258(20001230) 19:24<3401::AID-SIM554>3.0.CO;2-2 11122504 (Pubitemid 32056693)
25. P Chamnan RK Simmons SJ Sharp SJ Griffin NJ Wareham 2009 Cardiovascular risk assessment scores for people with diabetes: a systematic review Diabetologia 52 2001 2014 10.1007/s00125-009-1454-0 1:STN:280: DC%2BD1Mngt1ehsg%3D%3D 19629430
26. WA Davis S Colagiuri TM Davis 2009 Comparison of the Framingham and United Kingdom Prospective Diabetes Study cardiovascular risk equations in Australian patients with type 2 diabetes from the Fremantle Diabetes Study Med J Aust 190 180 184 19220181
27. RK Simmons RL Coleman HC Price, et al. 2009 Performance of the UK Prospective Diabetes Study risk engine and the Framingham risk equations in estimating cardiovascular disease in the EPIC-Norfolk Cohort Diabetes Care 32 708 713 10.2337/dc08-1918 19114615
28. AA van der Heijden MM Ortegon LW Niessen G Nijpels JM Dekker 2009 Prediction of coronary heart disease risk in a general, pre-diabetic, and diabetic population during 10 years of follow-up: accuracy of the Framingham, SCORE, and UKPDS risk functions: The Hoorn Study Diabetes Care 32 2094 2098 10.2337/dc09-0745 19875606
29. DW Hosmer T Hosmer S Le Cessie S Lemeshow 1997 A comparison of goodness-of-fit tests for the logistic regression model Stat Med 16 965 980 10.1002/(SICI)1097-0258(19970515)16:9<965::AID-SIM509>3.0.CO;2-O 1:STN:280:DyaK2szgsVaiuw%3D%3D 9160492 (Pubitemid 27198985)
30. WB Kannel RB D'Agostino 1995 The importance of cardiovascular risk factors in the elderly Am J Geriatr Cardiol 4 10 23 11416330
31. WB Kannel 2002 Coronary heart disease risk factors in the elderly Am J Geriatr Cardiol 11 101 107 10.1111/j.1076-7460.2002.00995.x 11872968 (Pubitemid 34614597)
32. CS Moller B Zethelius J Sundstrom L Lind 2006 Impact of follow-up time and re-measurement of the electrocardiogram and conventional cardiovascular risk factors on their predictive value for myocardial infarction J Intern Med 260 22 30 10.1111/j.1365-2796.2006.01642.x 16789975 (Pubitemid 43894066)
33. RB D'Agostino Sr S Grundy LM Sullivan P Wilson 2001 Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation Jama 286 180 187 10.1001/jama.286.2.180 11448281 (Pubitemid 32640849)
34. P McEwan JE Williams JD Griffiths, et al. 2004 Evaluating the performance of the Framingham risk equations in a population with diabetes Diabet Med 21 318 323 10.1111/j.1464-5491.2004.01139.x 1:STN:280:DC%2BD2c7lslaltw%3D%3D 15049932 (Pubitemid 38519665)
35. P Brindle A Beswick T Fahey S Ebrahim 2006 Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review Heart 92 1752 1759 10.1136/hrt.2006.087932 1:STN:280: DC%2BD28nmvFSrtA%3D%3D 16621883 (Pubitemid 44851316)
36. Steyerberg EW (2009) Clinical prediction models: a practical approach to development, validation, and updating. Springer, Rotterdam
37. AC Justice KE Covinsky JA Berlin 1999 Assessing the generalizability of prognostic information Ann Intern Med 130 515 524 1:STN:280:DyaK1M7msFCjsg%3D%3D 10075620